NBW Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$217K Buy
1,422
+147
+12% +$22.6K 0.05% 102
2025
Q1
$211K Buy
+1,275
New +$199K 0.05% 94
2024
Q2
Sell
-1,580
Closed -$250K 107
2024
Q1
$250K Buy
1,580
+288
+22% +$45.8K 0.05% 91
2023
Q4
$203K Sell
1,292
-292
-18% -$44.8K 0.04% 105
2023
Q3
$247K Sell
1,584
-166
-9% -$27.4K 0.06% 83
2023
Q2
$290K Buy
1,750
+320
+22% +$51.6K 0.07% 83
2023
Q1
$222K Buy
+1,430
New +$231K 0.05% 101
2022
Q2
Sell
-1,153
Closed -$204K 90
2022
Q1
$204K Buy
+1,153
New +$196K 0.05% 86

Other funds holding JNJ

NBW Capital's JNJ Position: Q2 2025 in Review

NBW Capital increased its Johnson & Johnson (JNJ) stake by 12% in Q2 2025, buying an estimated $22.6K and bringing the position to 1,422 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #102.

NBW Capital first reported a position in JNJ in Q1 2022 and has held it in 8 quarters since. The position peaked at $290K in Q2 2023. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • NBW Capital held 1,422 shares of Johnson & Johnson worth $217K as of Q2 2025.
  • NBW Capital bought 147 Johnson & Johnson shares in Q2 2025, an estimated $22.6K.
  • Johnson & Johnson made up 0.05% of NBW Capital's portfolio in Q2 2025, its #102 holding.
  • NBW Capital first reported a position in Johnson & Johnson in Q1 2022 and has held it in 8 quarters since.
  • NBW Capital's Johnson & Johnson position peaked at $290K in Q2 2023.
  • 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.